In the ever-evolving world of biotechnology, one microscopic marvel is making major waves: the Nanobody. Often described as “mini-antibodies,” nanobodies are a cutting-edge innovation with the potential to disrupt traditional therapies and redefine how we treat diseases—from cancer to viral infections. But what exactly are nanobodies, and why are biotech giants investing...